|
Restenosis
Citations 51-60 of 538 total displayed.
|
Past content
(since Jan 1999):
|
- Editorials
Drug-Eluting Stents: Dual Antiplatelet Therapy for Every Survivor?
- Anthony A. Bavry and Deepak L. Bhatt
Circulation 2007;116:696-699, doi:10.1161/CIRCULATIONAHA.107.719484
[Full text]
- Interventional Cardiology
Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length: The Femoral Artery Stenting Trial (FAST)
- Hans Krankenberg, Michael Schlüter, Hermann J. Steinkamp, Karlheinz Bürgelin, Dierk Scheinert, Karl-Ludwig Schulte, Erich Minar, Patrick Peeters, Marc Bosiers, Gunnar Tepe, Bernhard Reimers, Felix Mahler, Thilo Tübler, and Thomas Zeller
Circulation 2007;116:285-292; published online before print as doi:10.1161/CIRCULATIONAHA.107.689141
[Abstract]
[Full text]
- Advances in Interventional Cardiology
Drug-Eluting Stent Update 2007: Part I: A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same?
- Joost Daemen and Patrick W. Serruys
Circulation 2007;116:316-328, doi:10.1161/CIRCULATIONAHA.106.621342
[Full text]
- Interventional Cardiology
Long-Term Safety and Efficacy of Drug-Eluting Stents: Two-Year Results of the REAL (REgistro AngiopLastiche dell’Emilia Romagna) Multicenter Registry
- Antonio Marzocchi, Francesco Saia, Giancarlo Piovaccari, Antonio Manari, Enrico Aurier, Alberto Benassi, Alberto Cremonesi, Gianfranco Percoco, Elisabetta Varani, Paolo Magnavacchi, Paolo Guastaroba, Roberto Grilli, and Aleardo Maresta
Circulation 2007;115:3181-3188; published online before print as doi:10.1161/CIRCULATIONAHA.106.667592
[Abstract]
[Full text]
- Articles
Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length. The Femoral Artery Stenting Trial (FAST)
- Hans Krankenberg, Michael Schlüter, Hermann J. Steinkamp, Karlheinz Bürgelin, Dierk Scheinert, Karl-Ludwig Schulte, Erich Minar, Patrick Peeters, Marc Bosiers, Gunnar Tepe, Bernhard Reimers, Felix Mahler, Thilo Tübler, and Thomas Zeller
Circulation published June 25, 2007, doi:10.1161/CIRCULATIONAHA.107.689141
[Abstract]
- Articles
Long-Term Safety and Efficacy of Drug-Eluting Stents. Two-Year Results of the REAL (REgistro AngiopLastiche dell’Emilia Romagna) Multicenter Registry
- Antonio Marzocchi, Francesco Saia, Giancarlo Piovaccari, Antonio Manari, Enrico Aurier, Alberto Benassi, Alberto Cremonesi, Gianfranco Percoco, Elisabetta Varani, Paolo Magnavacchi, Paolo Guastaroba, Roberto Grilli, and Aleardo Maresta
Circulation published June 11, 2007, doi:10.1161/CIRCULATIONAHA.106.667592
[Abstract]
- Vascular Medicine
Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting
- Martin Schillinger, Schila Sabeti, Petra Dick, Jasmin Amighi, Wolfgang Mlekusch, Oliver Schlager, Christian Loewe, Manfred Cejna, Johannes Lammer, and Erich Minar
Circulation 2007;115:2745-2749; published online before print as doi:10.1161/CIRCULATIONAHA.107.688341
[Abstract]
[Full text]
- Articles
Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting
- Martin Schillinger, Schila Sabeti, Petra Dick, Jasmin Amighi, Wolfgang Mlekusch, Oliver Schlager, Christian Loewe, Manfred Cejna, Johannes Lammer, and Erich Minar
Circulation published May 14, 2007, doi:10.1161/CIRCULATIONAHA.107.688341
[Abstract]
- Cardiology Patient Pages
Drug-Eluting Stents
- William H. Maisel and Warren K. Laskey
Circulation 2007;115:e426-427e, doi:10.1161/CIRCULATIONAHA.107.688176
[Full text]
- Special Reports
Thrombosis in Coronary Drug-Eluting Stents: Report From the Meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7–8, 2006
- Warren K. Laskey, Clyde W. Yancy, and William H. Maisel
Circulation 2007;115:2352-2357, doi:10.1161/CIRCULATIONAHA.107.688416
[Full text]
|
|
